Phase 3 Research Trial for Atopic Dermatitis – Eczema 5 (68 Weeks)

Recruiting adolescents from 12 to less than 18 years of age with a diagnosis of atopic dermatitis (AD) for at least 6 months for this research trial. To qualify for the study, individuals must have moderate to severe disease with AD involvement of ≥10% body surface area. In addition, eligible participants must have a history of inadequate response to topical corticosteroids (TCS) of medium or higher potency within 6 months, or
for whom topical treatments are otherwise medically inadvisable.

Participants will receive an investigational medication (active study drug) or placebo via injection, and in combination with topical treatment. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will be provided.

Study participation will last about 68 weeks and involve about 19 visits to the study centre.

If interested, please contact our Research Coordinator  at 416-633-0001 x 4 or e-mail [email protected].

    Shopping Bag
    Your cart is emptyReturn to Shop
      Calculate Shipping
      Apply Coupon